Unsurprisingly, studies show that social distancing during the COVID-19 pandemic has a significant negative impact on mental well-being. The rapidly growing demand from affected people for mental health services and technologies was immediately picked up by the venture capital industry. While investments in mental health startups (HealthTech) remained stable in 2018 and 2019, the number of deals increased by +43% and total deal volume more than doubled in 2020.
About FCF Life Sciences
FCF Life Sciences advises leading healthcare companies in Europe on financing transactions (equity, debt, and licensing) with regional and international investors. Our team consists of science-driven industry and finance experts with a strong track record in managing financing processes. We thrive to maximize the efficiency in the fundraising process and increase its closing probability.
Learn more about FCF Life Sciences, click here.
We closely track the activity in the financial markets and are passionate about capital markets research. Not every idea or research question make it into the final selection for our publications. However, we generate interesting information on financing trends in Life Sciences sector, which we would like to share in our blog.
To hear from us on the latest insights, please sign up here: